Pharmaceutical packaging must protect a drug product from moisture, oxygen, light, and contamination while remaining compatible with the product and the filling process. High-barrier metallized CPP (cast polypropylene) film can serve as a barrier layer within a qualified flexible laminate, but it is not a standalone packaging solution and does not by itself guarantee drug stability.
This article explains how metallized CPP contributes to pharmaceutical protection, where it is typically used, and what must be validated. It is provided for general technical information only; see the disclaimer at the end.
Why barrier performance matters
Drug stability depends on the formulation, the packaging system, storage conditions, and the interaction between the product and its container. Moisture, oxygen, and light can each contribute to degradation, but the sensitivity of a given product must be established through stability studies.
A barrier film can reduce the rate at which moisture, oxygen, or light reaches the product. It cannot compensate for an unsuitable formulation, an inadequate seal, or a package design that is not qualified for the intended shelf life.
How metallized CPP contributes
High-barrier metallized CPP film is produced by depositing a thin aluminum layer onto a cast CPP substrate under vacuum. The aluminum layer provides a metallic appearance and contributes barrier against moisture, oxygen, and light. The CPP substrate provides mechanical strength, heat-sealability in appropriate structures, and compatibility with lamination.
In a pharmaceutical laminate, the metallized layer is normally not the product-contact surface. A qualified sealant or product-contact layer is required, and the complete structure—not the metallized film alone—determines extractables, leachables, seal integrity, and barrier performance.
Moisture barrier
A continuous aluminum layer reduces water vapor transmission, helping limit moisture ingress into the package. This is relevant for moisture-sensitive solid dosage forms and for products whose stability is affected by humidity. The actual WVTR depends on the aluminum layer, the adhesive, the sealant, and the converting process, and should be measured on the finished laminate.
Oxygen barrier
Metallized CPP also reduces oxygen transmission, which can help limit oxidation of oxygen-sensitive components. Oxygen barrier performance varies with the metallized layer, the laminate structure, and the package format; it should be verified for the specific product and shelf life.
Light protection
The aluminum layer reduces light transmission, including a portion of ultraviolet and visible light. The level of protection depends on optical density and coating continuity. For light-sensitive drugs, light transmission of the finished package should be measured, and additional opaque or UV-absorbing layers may be required.
Where metallized CPP is used
Metallized CPP is used as a barrier layer in flexible pharmaceutical laminates, including sachets and strip packs for powders, granules, and other solid dosage forms. Some oral liquid or semi-solid products may use flexible pouches, but the film must be part of a qualified laminate with an appropriate product-contact layer; metallized CPP alone is not intended for direct contact with a liquid drug product.
Other dosage forms—such as tablets, capsules, and injectables—use different primary packaging systems. Metallized CPP may appear only in specific lidding, secondary, or protective structures, if at all. The suitability of any structure must be confirmed with the drug product and the packaging system.
Advantages and limits
Metallized CPP offers a combination of barrier performance, metallic appearance, mechanical strength, and compatibility with flexible converting processes. These properties can support package design where moisture, oxygen, and light protection are required.
The limits are equally important:
- It is a barrier layer, not a complete package; a sealant and product-contact layer are required.
- Barrier performance depends on the full laminate and the sealing process.
- The metallized layer must adhere reliably through lamination, printing, and handling.
- Pharmaceutical use requires qualification for extractables, leachables, compatibility, and the destination market’s regulatory requirements.
Quality and regulatory considerations
Production control should cover aluminum deposition, optical density, coating uniformity, adhesion, and roll consistency. Finished-product testing typically includes WVTR and OTR on the laminate, seal strength and integrity, and adhesion before and after lamination.
For pharmaceutical applications, the packaging system should be supported by appropriate documentation, including a grade-specific TDS, change-control procedures, and compliance information for the destination market. The marketing authorisation holder remains responsible for demonstrating that the packaging system is suitable for the drug product.
Outlook
Demand for stable, well-protected drug products continues to increase, and packaging requirements are becoming more specific. Metallized CPP is likely to remain one option among several barrier structures, with selection driven by the dosage form, shelf life, sterilization or retort conditions, and regulatory requirements. Manufacturers are also under pressure to reduce energy use and waste; environmental claims should be supported by market-specific evidence rather than assumed from the material category.
Disclaimer
This article is provided for general technical information only. It is not regulatory, medical, or legal advice, and it does not confirm that any film, laminate, or package is suitable for a particular drug product or market.
Pharmaceutical packaging must be qualified for the specific drug product, dosage form, filling process, sterilization or retort conditions, shelf life, and destination market. Food-contact and pharmaceutical compliance—including applicable pharmacopoeial and regulatory requirements—must be verified with the relevant authorities and the marketing authorisation holder. Performance values are typical and must be confirmed against a grade-specific TDS and finished-package testing. SDL Packs makes no representation that any film is suitable for direct contact with a drug product; a qualified product-contact layer and packaging system are required.
Next step
Review our metallized CPP film platform or send your dosage form, package structure, and barrier requirements through our technical inquiry form. We can discuss a starting grade and the documentation available for evaluation.